Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.700 $1.03 Friday, 10th May 2024 HOOK stock ended at $0.768. This is 4.00% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.46% from a day low at $0.740 to a day high of $0.81.
90 days $0.605 $1.03
52 weeks $0.410 $2.05

Historical Hookipa Pharma Inc. prices

Date Open High Low Close Volume
Oct 05, 2023 $0.570 $0.581 $0.555 $0.572 385 930
Oct 04, 2023 $0.590 $0.595 $0.550 $0.556 155 384
Oct 03, 2023 $0.603 $0.610 $0.567 $0.598 248 604
Oct 02, 2023 $0.630 $0.630 $0.585 $0.599 114 242
Sep 29, 2023 $0.610 $0.630 $0.605 $0.616 144 727
Sep 28, 2023 $0.630 $0.630 $0.600 $0.601 149 298
Sep 27, 2023 $0.600 $0.640 $0.550 $0.625 1 794 492
Sep 26, 2023 $0.565 $0.600 $0.565 $0.594 137 762
Sep 25, 2023 $0.600 $0.605 $0.550 $0.581 289 987
Sep 22, 2023 $0.613 $0.625 $0.590 $0.600 311 768
Sep 21, 2023 $0.620 $0.630 $0.602 $0.610 195 317
Sep 20, 2023 $0.620 $0.633 $0.610 $0.613 169 110
Sep 19, 2023 $0.646 $0.670 $0.616 $0.616 271 256
Sep 18, 2023 $0.701 $0.710 $0.645 $0.645 425 466
Sep 15, 2023 $0.700 $0.730 $0.695 $0.700 621 579
Sep 14, 2023 $0.730 $0.740 $0.685 $0.685 364 237
Sep 13, 2023 $0.750 $0.750 $0.690 $0.717 735 877
Sep 12, 2023 $0.709 $0.709 $0.681 $0.686 152 535
Sep 11, 2023 $0.670 $0.711 $0.670 $0.685 99 578
Sep 08, 2023 $0.710 $0.710 $0.670 $0.684 155 562
Sep 07, 2023 $0.690 $0.690 $0.660 $0.675 184 915
Sep 06, 2023 $0.680 $0.694 $0.664 $0.691 187 529
Sep 05, 2023 $0.671 $0.719 $0.652 $0.694 307 906
Sep 01, 2023 $0.672 $0.689 $0.646 $0.681 279 946
Aug 31, 2023 $0.643 $0.676 $0.640 $0.655 488 265
Click to get the best stock tips daily for free!

About Hookipa Pharma Inc.

Hookipa Pharma. HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-2... HOOK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT